Shares of Novartis AG (NYSE:NVS) have been given an average recommendation of “Hold” by the eighteen research firms that are currently covering the stock. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $92.75.

A number of analysts have commented on NVS shares. Zacks Investment Research downgraded Novartis AG from a “hold” rating to a “sell” rating in a research report on Wednesday, September 21st. JPMorgan Chase & Co. reiterated a “buy” rating on shares of Novartis AG in a research report on Tuesday, September 13th. Argus reiterated a “hold” rating on shares of Novartis AG in a research report on Thursday, August 25th. Chardan Capital decreased their target price on Novartis AG from $95.00 to $92.00 and set a “buy” rating on the stock in a research report on Monday, October 10th. Finally, Bank of America Corp. reiterated a “hold” rating on shares of Novartis AG in a research report on Tuesday, July 12th.

Shares of Novartis AG (NYSE:NVS) opened at 76.09 on Wednesday. Novartis AG has a 12 month low of $69.90 and a 12 month high of $94.63. The company’s 50 day moving average price is $79.33 and its 200-day moving average price is $78.96. The firm has a market capitalization of $181.19 billion, a P/E ratio of 27.17 and a beta of 0.57.

Novartis AG (NYSE:NVS) last posted its earnings results on Tuesday, July 19th. The company reported $1.23 EPS for the quarter, topping the Zacks’ consensus estimate of $1.18 by $0.05. The company had revenue of $12.47 billion for the quarter, compared to the consensus estimate of $12.33 billion. Novartis AG had a return on equity of 15.33% and a net margin of 13.84%. During the same period in the previous year, the business earned $1.25 earnings per share. On average, equities analysts predict that Novartis AG will post $4.72 earnings per share for the current fiscal year.

Large investors have recently made changes to their positions in the company. Sunbelt Securities Inc. raised its stake in shares of Novartis AG by 0.3% in the second quarter. Sunbelt Securities Inc. now owns 4,545 shares of the company’s stock valued at $375,000 after buying an additional 15 shares in the last quarter. PacWest Financial Management Inc raised its stake in shares of Novartis AG by 0.4% in the third quarter. PacWest Financial Management Inc now owns 6,254 shares of the company’s stock valued at $494,000 after buying an additional 25 shares in the last quarter. Wealthsource Partners LLC raised its stake in shares of Novartis AG by 1.3% in the second quarter. Wealthsource Partners LLC now owns 2,907 shares of the company’s stock valued at $240,000 after buying an additional 38 shares in the last quarter. Ameritas Investment Partners Inc. raised its stake in shares of Novartis AG by 0.3% in the second quarter. Ameritas Investment Partners Inc. now owns 13,133 shares of the company’s stock valued at $1,083,000 after buying an additional 44 shares in the last quarter. Finally, Private Trust Co. NA raised its stake in shares of Novartis AG by 1.7% in the second quarter. Private Trust Co. NA now owns 2,899 shares of the company’s stock valued at $239,000 after buying an additional 48 shares in the last quarter. Institutional investors own 9.77% of the company’s stock.

Novartis AG Company Profile

Novartis AG is a holding company. The Company specializes in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals, including eye care products. Its portfolio includes medicines, eye care and generic pharmaceuticals. The Company’s segments include Pharmaceuticals, Alcon and Sandoz.

5 Day Chart for NYSE:NVS

Receive News & Stock Ratings for Novartis AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novartis AG and related stocks with our FREE daily email newsletter.